Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Gene Therapy
32 Articles Available
2
2
Can't find what you're looking for? Try our
advanced search
.
CRISPR
MilliporeSigma Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology
PR-M09-18-NI-046
Partnership
Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership
PR-M08-18-NI-049
Cell and Gene Therapy
Global Gene Therapy Market Opportunity Analysis and Industry Forecast, 2023
PR-M06-18-NI-043
Viral Vector
Flexible, Mobile, Modular: High-Containment Viral Vector Center of Excellence
PAP-Q2-18-CL-005
Partnership
4DMT and ROCHE Expand Ophthalmology Partnership to Develop and Commercialize Multiple AAV Gene Therapy Products
PR-M05-18-NI-014
Cell and Gene Therapy
FDA Approves Gene Therapy
PAO-M01-18-NI-005
CRISPR
CRISPR Technology Could Enable New Treatments for Resistant Fungal Infections
PAO-M11-17-NI-006
FDA
Gene Therapy for Hemophilia A Granted Breakthrough Therapy Designation
PAO-M10-17-NI-047
«
2
2
